KC
PFE icon

Kepler Cheuvreux’s Pfizer PFE Stock Holding History

Kepler Cheuvreux’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.8M Buy
1,405,592
+709,523
+102% +$18.6M 1.94% 17
2026
Q1 		$19.5M Buy
696,069
+122,385
+21% +$3.26M 1.3% 26
2025
Q4 		$14.3M Sell
573,684
-78,312
-12% -$1.97M 0.81% 42
2025
Q3 		$16.6M Buy
+651,996
New +$16.1M 0.89% 40

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kepler Cheuvreux's PFE Position: Q2 2026 in Review

Kepler Cheuvreux increased its Pfizer (PFE) stake by 102% in Q2 2026, buying an estimated $18.6M and bringing the position to 1,405,592 shares worth $33.8M. The position accounts for 1.94% of the portfolio, ranked #17.

Kepler Cheuvreux first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Kepler Cheuvreux held 1,405,592 shares of Pfizer worth $33.8M as of Q2 2026.
  • Kepler Cheuvreux bought 709,523 Pfizer shares in Q2 2026, an estimated $18.6M.
  • Pfizer made up 1.94% of Kepler Cheuvreux's portfolio in Q2 2026, its #17 holding.
  • Kepler Cheuvreux first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kepler Cheuvreux's 13F filing for Q2 2026, filed 15 Jul 2026.